Red blood cell transfusion practices: comparison with the 3rd European Multicenter Trial of EPO25
| Ulm No EPO | EPO trial | ||||
|---|---|---|---|---|---|
| 750 IU EPO /week | 1500 IU EPO /week | ||||
| Number | 88 | 92 | 91 | ||
| Birth weight (g) | 810 (710;900) | 793 (678;890) | 800 (680;920) | ||
| Gestational age (weeks) | 26 (25;27) | 26 (25;27) | 27 (25;28) | ||
| Gestational age <28 weeks | 77 (88) | 139 (76) | |||
| Gestational age 28–29 weeks | 11 (13) | 44 (24) | |||
| Not transfused (after day 3) | 31 (35) | 29 (32) | 29 (32) | ||
| Infants with 1 RBCT | 21 (24) | 19 (21) | 20 (22) | ||
| Infants with 2 RBCT | 18 (20) | 14 (15) | 14 (15) | ||
| Infants with 3 RBCT | 8 (9) | 8 (9) | 5 (5) | ||
| Infants with >3 RBCT | 11 (13) | 22 (24) | 23 (25) | ||
| Volume transfused (ml/infant) | 19.3 (0;33.6) | 12.9 (0;22.0) | 10.5 (0;25.0) | ||
As appropriate, values are median (quartiles) or number (%).
EPO, Erythropoietin; RBCT, red blood cell transfusion.